Suchergebnisse - "Lubel, John S"

PubPharm (62)

21

Lessons From COVID-19, ACE2, and Intestinal Inflammation : Could a Virus Trigger Chronic Intestinal Inflammation?

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2021

von Hanrahan, T. | Lubel, J. | Garg, M.

CommentOn: Clin Gastroenterol Hepatol. 2020 Jul;18(8):1663-1672. - PMID 32278065

22

Current issues in the prevalence, diagnosis and management of hepatocellular carcinoma in Australia

enthalten in: Internal Medicine Journal | 2021

von Lubel, J. | Roberts, S. | Howell, J. | +2

23

Australian recommendations for the management of hepatocellular carcinoma : a consensus statement

enthalten in: Medical Journal of Australia | 2021

von Lubel, J. | Roberts, S. | Strasser, S. | +7

24

Prevalence of non‐alcoholic fatty liver disease in regional Victoria : a prospective population‐based study

enthalten in: Medical Journal of Australia | 2021

von Roberts, S. | Majeed, A. | Glenister, K. | +5

25

Australian recommendations for the management of hepatocellular carcinoma

enthalten in: Medical Journal of Australia | 2021

von Lubel, J. | Roberts, S. | Strasser, S. | +1

26

Gastrointestinal ACE2, COVID-19 and IBD : Opportunity in the Face of Tragedy?

enthalten in: Gastroenterology | 2020

von Garg, M. | Christensen, B. | Lubel, J.

CommentOn: Gastroenterology. 2020 May;158(6):1831-1833.e3. - PMID 32142773

27

Letter : ACE2, IBD and COVID-19-why IBD patients may be at reduced risk of COVID-19

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Prentice, R. | Tjandra, D. | Garg, M. | +5

CommentOn: Aliment Pharmacol Ther. 2020 Jul;52(2):276-283. - PMID 32359205

28

A systematic review on the complications and management of hepatic adenomas : a call for a new approach

enthalten in: European journal of gastroenterology & hepatology | 2020

von Rodrigues, B. | Mei, S. | Fox, A. | +2

29

Letter : intestinal inflammation, COVID-19 and gastrointestinal ACE2-exploring RAS inhibitors

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Garg, M. | Royce, S. | Lubel, J.

CommentOn: Aliment Pharmacol Ther. 2020 Jul;52(2):276-283. - PMID 32359205

30

Epidemiology and outcomes of marked elevations of alanine aminotransferase >1000 IU/L in an Australian cohort

enthalten in: JGH open : an open access journal of gastroenterology and hepatology | 2020

von Con, D. | Buckle, A. | Nicoll, A. | +1